Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, with limited treatment options and a high recurrence rate. Emerging research suggests that the tumor microenvironment (TME) and metastatic site play a critical role in therapy response. In this webinar, Yana Zavros will discuss how she combined spatial biology and patient-derived organoids (PDOs) to uncover a distinct cell population driving therapy resistance and disease recurrence in PDAC.
Topics to be covered:
- Mapping the TME across metastatic sites to guide treatment strategies
- Using spatial biology and PDOs to identify therapy-resistant cell populations in PDAC
- An introduction to high throughput multiplex immunofluorescence for TME characterization
Tuesday, May 6th, 2025 | 11:00 AM - 12:30 PM Eastern Time
This webinar will be available to view live and on demand.
Speaker
Yana Zavros, PhD
Research Center Director and GRA Eminent Scholar in Molecular Medicine
University of Georgia School of Medicine
.jpg "Tad George, PhD")
Tad George, PhD
Senior Vice President, Biology R&D
RareCyte Inc.
